Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity

Steritas LLC., a company dedicated to enhancing patient care for steroid-treated patients announced that Alder Hey Children’s NHS Foundation Trust, and the Liverpool Clinical Trials Centre will apply its Steritas Pediatric Glucocorticoid Toxicity Index (pGTI) in a clinical trial to compare efficacy, safety and cost-effectiveness of intravenous versus oral glucocorticoids (steroids) for children and young people with Juvenile Idiopathic Arthritis (JIA).

The randomized controlled trial, called STAR-JIA trial (Steroid TreAtment TRial in JIA), aims to understand not only which route of steroid is the most effective for treating inflammation in JIA, but will also implement the pGTI to compare the toxicity of intravenous versus oral steroids, marking a significant advancement in pediatric rheumatology. The study is funded by the National Institute for Health and Care Research.

Juvenile idiopathic arthritis is the most common rheumatic disease in children. Glucocorticoids (oral and intravenous) and methotrexate are the standard of care, even with limited evidence about optimal dosing, comparative effectiveness, safety and cost-effectiveness of intravenous versus oral glucocorticoids.

The Steritas pGTI provides a systematic approach to assessing steroid-toxicity in children between the ages of 2 and 18 years. It is used to measure and monitor steroid-toxicity in young patients.The instrument provides weighted scores of steroid-toxicity that equip researchers, clinicians and regulators to evaluate the impact of steroid-sparing treatments. The pGTI is fast, accurate, and easy to implement.Use of the Steritas pGTI in this research initiative will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children. 

Associate Professor Clare Pain, leading the trial across the UK, highlighted the potential of this initiative: "By integrating advanced clinical outcome assessments like the pGTI into clinical trials, we are not just advancing research but also directly enhancing clinical practice and patient health."

The pGTI was developed at the Massachusetts General Hospital with an international group of pediatric subspecialists. Steritas is the sole licensing entity worldwide for the pGTI, which is part of Steritas’ STOX® Suite of clinical outcome assessments of steroid toxicity.

The STAR-JIA trial is embarking on a vital new approach to measuring steroid-toxicity in the clinic as part of a randomized clinical trial. We are pleased to be part of Dr Pain’s research across the United Kingdom and celebrate this first use of the pGTI - clinical research tool - at point of care. The pGTI, is part of our STOX® Suite of clinical outcome assessments of steroid toxicity which are being used in 80 countries and 1100 trial sites across the world, and in some 28 different diseases. Its first use in clinical practice is an opportunity to catch emerging toxicity before it does lasting harm to patients.”

Martha Stone, CEO, Steritas

Chief Investigators – Associate Professor Clare Pain & Professor Athimalaipet Ramanan.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Steritas LLC. (2024, September 25). Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity. News-Medical. Retrieved on October 07, 2024 from https://www.news-medical.net/news/20240925/Steritas-Pediatric-Glucocorticoid-Toxicity-Index-applied-by-Alder-Hey-Childrens-NHS-Foundation-Trust-and-Liverpool-Clinical-Trials-Centre-in-clinical-trial-to-assess-steroid-toxicity-in-children-with-juvenile-idiopathic-arthritis.aspx.

  • MLA

    Steritas LLC. "Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity". News-Medical. 07 October 2024. <https://www.news-medical.net/news/20240925/Steritas-Pediatric-Glucocorticoid-Toxicity-Index-applied-by-Alder-Hey-Childrens-NHS-Foundation-Trust-and-Liverpool-Clinical-Trials-Centre-in-clinical-trial-to-assess-steroid-toxicity-in-children-with-juvenile-idiopathic-arthritis.aspx>.

  • Chicago

    Steritas LLC. "Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity". News-Medical. https://www.news-medical.net/news/20240925/Steritas-Pediatric-Glucocorticoid-Toxicity-Index-applied-by-Alder-Hey-Childrens-NHS-Foundation-Trust-and-Liverpool-Clinical-Trials-Centre-in-clinical-trial-to-assess-steroid-toxicity-in-children-with-juvenile-idiopathic-arthritis.aspx. (accessed October 07, 2024).

  • Harvard

    Steritas LLC. 2024. Steritas' Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity. News-Medical, viewed 07 October 2024, https://www.news-medical.net/news/20240925/Steritas-Pediatric-Glucocorticoid-Toxicity-Index-applied-by-Alder-Hey-Childrens-NHS-Foundation-Trust-and-Liverpool-Clinical-Trials-Centre-in-clinical-trial-to-assess-steroid-toxicity-in-children-with-juvenile-idiopathic-arthritis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.